TOI
Oncology Institute Inc/the
$2.07
Earnings Summary
Revenue | $82.04Mn |
Net Profits | $-17.42Mn |
Net Profit Margins | -21.23% |
Highlights
Oncology Institute Inc/the’s revenue jumped 26.25% since last year same period to $82.04Mn in the Q3 2023. On a quarterly growth basis, Oncology Institute Inc/the has generated 2.26% jump in its revenue since last 3-months.
Oncology Institute Inc/the’s net profit fell -551.42% since last year same period to $-17.42Mn in the Q3 2023. On a quarterly growth basis, Oncology Institute Inc/the has generated -3.09% fall in its net profits since last 3-months.
Oncology Institute Inc/the’s net profit margin fell -415.97% since last year same period to -21.23% in the Q3 2023. On a quarterly growth basis, Oncology Institute Inc/the has generated -0.81% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Oncology Institute Inc/the post its latest quarter earnings
EPS Estimate Current Quarter | -0.11 |
EPS Estimate Current Year | -0.11 |
Highlights
Oncology Institute Inc/the’s earning per share (EPS) estimates for the current quarter stand at -0.11 - a 15.38% jump from last quarter’s estimates.
Oncology Institute Inc/the’s earning per share (EPS) estimates for the current year stand at -0.11.
Key Ratios
Key ratios of the Oncology Institute Inc/the post its Q3 2023 earnings
Earning Per Share (EPS) | -0.19 |
Highlights
Oncology Institute Inc/the’s earning per share (EPS) jumped 24% since last year same period to -0.19 in the Q3 2023. This indicates that the Oncology Institute Inc/the has generated 24% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-09 | -0.17 | -0.19 | -11.76% |
2023-11-08 | -0.13 | -0.19 | -46.15% |
2023-05-10 | -0.17 | -0.33 | -94.12% |
₹0 US Stocks a/c Opening Fee